Dl- -(4-isobutyl(cyclohexen-1-yl))aklanoic acids and derivatives as fibrinolytic and thrombolytic compounds.
D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors; D000818:Animals; D002351:Carrageenan; D055598:Chemical Phenomena; D002621:Chemistry; D003509:Cyclohexanecarboxylic Acids; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005343:Fibrinolytic Agents / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D006801:Humans; D007928:Lethal Dose 50; D051379:Mice; D010973:Platelet Adhesiveness / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D013329:Structure-Activity Relationship; D013917:Thrombin / Q000037:antagonists & inhibitors; D013997:Time Factors
D003509:Cyclohexanecarboxylic Acids; D005343:Fibrinolytic Agents; D000244:Adenosine Diphosphate; D002351:Carrageenan; D013917:Thrombin; D004837:Epinephrine